Joerg Willuda
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
-
- Atherosclerosis and Cardiovascular Diseases
- Toxin Mechanisms and Immunotoxins
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 4
- Radiopharmaceutical Chemistry and Applications 2
- Oncology 4
- Peptidase Inhibition and Analysis 2
- HER2/EGFR in Cancer Research 2
- Co-authors
- Rolf A. Stahel (1 shared paper)Annemarie Honegger (1 shared paper)Andreas Plückthun (1 shared paper)P. August Schubiger (1 shared paper)Robert Waibel (1 shared paper)Uwe Zangemeister‐Wittke (1 shared paper)Eckart Fleck (1 shared paper)Thore Dietrich (1 shared paper)
- Journals
- Cancer Research (2 papers)Translational Oncology (1 paper)Gene Therapy (1 paper)Atherosclerosis (1 paper)Targeted Oncology (1 paper)
- Partner nations
- GermanySwitzerlandSingapore
In The Last Decade
Joerg Willuda
9 papers receiving 313 citations
Peers
Comparison fields: 5 of 57
- Radiology, Nuclear Medicine and Imaging 148
- Immunology 98
- Biotechnology 28
- Oncology 76
- Immunology and Allergy 17
Countries citing papers authored by Joerg Willuda
This map shows the geographic impact of Joerg Willuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joerg Willuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joerg Willuda more than expected).
Fields of papers citing papers by Joerg Willuda
This network shows the impact of papers produced by Joerg Willuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joerg Willuda. The network helps show where Joerg Willuda may publish in the future.
Co-authors
The 25 scholars most cited alongside Joerg Willuda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | High thermal stability is essential for tumor targeting of antibody fragments: engineering of a humanized anti-epithelial glycoprotein-2 (epithelial cell adhesion molecule) single-chain Fv fragment. | 1999 | 178 |
| 2 | 2011 | 62 | |
| 3 | 2006 | 35 | |
| 4 | 2008 | 28 | |
| 5 | 2022 | 17 | |
| 6 | 2008 | 11 | |
| 7 | 2019 | 4 | |
| 8 | 2004 | 2 | |
| 9 | 2013 | 1 | |
| 10 | 2025 | 0 |
About Joerg Willuda
Joerg Willuda is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Molecular Biology, Immunology and Cellular and Molecular Neuroscience, having authored 10 papers that have together received 338 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (4 papers), Peptidase Inhibition and Analysis (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers), HER2/EGFR in Cancer Research (2 papers), Angiogenesis and VEGF in Cancer (1 paper), Glycosylation and Glycoproteins Research (1 paper), Protein purification and stability (1 paper) and Virology and Viral Diseases (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (148 citations), Immunology (98 citations), Biotechnology (28 citations), Oncology (76 citations) and Immunology and Allergy (17 citations). Joerg Willuda has collaborated with scholars based in Germany, Switzerland and Singapore. Frequent co-authors include Rolf A. Stahel, Annemarie Honegger, Andreas Plückthun, P. August Schubiger, Robert Waibel, Uwe Zangemeister‐Wittke, Eckart Fleck, Thore Dietrich, Kirstin Atrott and Thomas Hucko. Their work appears in journals such as Cancer Research, Translational Oncology, Gene Therapy, Atherosclerosis and Targeted Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.